Cognition Therapeutics INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Bios Equity Partners and affiliated entities report a material decrease in their beneficial ownership percentage of Cognition Therapeutics, Inc. common stock.